BioTTT001 injection
IIT-01-108
Phase 1 mab terminated
Quick answer
BioTTT001 injection for Locally Advanced Breast Cancer (LABC) is a Phase 1 program (mab) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Indication
- Locally Advanced Breast Cancer (LABC)
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated